Massage treatment method for xerophthalmia

Abstract

The invention provides a xerophthalmia massage treatment method which comprises the following steps: mounting a treatment execution device on the eyes of a patient, so that a first surface of a stroke termination end forms an annular contact surface with eyeballs, and a second surface of the stroke termination end abuts against the inner side surfaces of eyelids; a non-closed cavity is formed between the eyeball and the stroke stopping end to control the stroke propelling end to generate a progressive stroke relative to the eyelid of the patient, the progressive stroke is stopped in response to pain feedback of the patient, the treatment pressure range of the patient is obtained, and local anesthetic is applied to the eye of the patient through an operation window on the stroke stopping end. The control stroke advancement end generates a progressive stroke and a progressive stroke relative to the patient's eyelid circulation to apply a pressure within the therapeutic pressure range. The anesthetic application node is delayed, the treatment pressure range of the patient is determined in a personalized mode, one person has one strategy, an operator and the patient do not need to be worried about too large or too small treatment pressure any more, and the safety of the patient is guaranteed.

Description

Technical Field

[0001] This invention relates to the field of medical devices, and more particularly to a massage therapy for dry eye syndrome. Background Technology

[0002] Dry eye disease has a significantly rising incidence rate in my country, becoming one of the most common eye diseases. Its pathological characteristics are mainly manifested as tear secretion disorders and ocular surface damage caused by meibomian gland dysfunction (MGD). Currently, eyelid massage therapy is a core method for improving meibomian gland secretion function in clinical treatment, but traditional procedures have significant drawbacks. Before treatment, instilling ocular anesthetics can temporarily block the transmission of sensory nerve signals on the ocular surface, reducing discomfort such as pain and foreign body sensation caused by the treatment or ocular surface stimulation. On the one hand, during treatment, the patient may be unable to perceive pain due to anesthesia, and excessive pressure during massage can lead to eyelid damage, causing additional suffering. On the other hand, anesthetics mainly act on the corneal and conjunctival epithelial tissues. The conjunctival sac is the main space for anesthetic administration but not the primary anesthetic area, while the cornea, although the primary anesthetic area, cannot accommodate anesthetics. This necessitates the instillation of excessive amounts of anesthetic to maintain patient tolerance, resulting in uncontrollable anesthetic dosage. If the patient experiences pain due to anesthesia failure during treatment, the procedure must be interrupted, the instrument removed, and the anesthetic re-infused before reinsertion. This process is cumbersome and inconvenient, severely impacting treatment efficiency. Therefore, there is an urgent need to develop a treatment method that avoids additional pain for patients and simplifies the procedure. Summary of the Invention

[0003] To address the aforementioned problems, this invention provides a massage therapy method for dry eye syndrome, comprising the following steps: First, installing a treatment actuator onto the patient's eye, such that the first surface of the stroke termination end forms a ring-shaped contact surface with the eyeball, and the second surface of the stroke termination end abuts against the inner surface of the eyelid, forming a non-sealed cavity between the eyeball and the stroke termination end; Second, controlling the stroke advancement end to generate a gradual stroke relative to the patient's eyelid, stopping the gradual stroke in response to the patient's pain feedback, and obtaining the patient's treatment pressure range; Third, while maintaining the treatment actuator on the patient's eye, applying a local anesthetic to the patient's eye through the operating window on the stroke termination end, the anesthetic permeating the patient's eyeball through the operating window; Fourth, controlling the stroke advancement end to generate a gradual stroke and a gradual retraction stroke relative to the patient's eyelid circulation to apply pressure within the treatment pressure range.

[0004] In a further embodiment, in the third step, the anesthetic is also guided to the eyelids via a flow channel provided at the end of the travel.

[0005] Specifically, the anesthetic first reaches the surface of the eyeball through the operating window, then rises along the inner wall of the operating window to the intersection of the operating window and the flow channel, and finally is guided to the eyelid through the flow channel.

[0006] In a further embodiment, the anesthetic is guided to one eyelid via a first channel provided in the end of the travel, and to the other eyelid via a second channel provided in the end of the travel.

[0007] In a further embodiment, the anesthetic rises sequentially along the inner wall of the operating window to the intersection of the operating window and the second flow channel, and then to the intersection of the operating window and the first flow channel. It is then guided to one of the eyelids via the first flow channel and to the other eyelid via the second flow channel.

[0008] In a further embodiment, the anesthetic is guided to one eyelid via a first channel and to the other eyelid via a third channel communicating with the second channel.

[0009] In another embodiment, the anesthetic rises along the inner wall of the operating window to the intersection of the operating window and the first and second flow channels, and is simultaneously guided to one and the other eyelids through the first and second flow channels, respectively.

[0010] In another embodiment, the anesthetic first reaches the intersection of the operating window and the flow channel through the operating window, then is guided to the eyelid through the flow channel, and finally is guided to the surface of the eyeball through the through-hole below the eyelid.

[0011] In a further embodiment, the anesthetic is directed to one eyelid via a first channel and to the other eyelid via a second channel.

[0012] In a specific implementation, the flow channel is located on the second side of the end of the stroke to realize the guiding path of the anesthetic.

[0013] In a specific implementation, the flow channel is located between the first surface of the stroke termination end and the second surface of the stroke termination end to realize the guiding path of the anesthetic.

[0014] In another implementation, in the first step, the first surface of the travel-propelling end abuts against the outer surface of the eyelid.

[0015] In another embodiment, the first surface of the end of the stroke in the first step forms a segmented annular contact surface with the eyeball, thus realizing more embodiments based on the various embodiments of the above-mentioned massage treatment method for dry eye syndrome.

[0016] In another embodiment, in the first step, the treatment execution device in the first state is installed on the patient's eye. In the second step, the treatment execution device is first switched to the second state and then controlled. More embodiments are implemented based on the various embodiments of the above-mentioned dry eye massage treatment method.

[0017] In a further embodiment, in the third step, the treatment actuator is restored to the first state, and a local anesthetic is applied to the patient's eye through the operation window on the end of the stroke; in the fourth step, the treatment actuator is restored to the second state, and the stroke advancement end is controlled relative to the patient's eyelid for gradual advancement and retraction to apply pressure within the treatment pressure range.

[0018] This invention personalizes the treatment pressure range for each patient by delaying the application of anesthetic, achieving a customized approach for each individual. Neither the operator nor the patient needs to worry about excessive or insufficient treatment pressure, ensuring patient safety. Furthermore, this invention significantly improves the overall anesthetic effect and further enhances patient comfort by strategically adjusting the anesthetic guidance path and adding massage and compression targets (eyelids). Attached Figure Description

[0019] Figure 1 Schematic diagram of the dry eye massage therapy system.

[0020] Figure 2 Schematic diagram of the treatment execution device installation.

[0021] Figure 3 One of the schematic diagrams of a treatment execution device.

[0022] Figure 4 Schematic diagram of the cross-section of the treatment execution device in contact with the eyeball.

[0023] Figure 5 Schematic diagram of the treatment execution device (second one).

[0024] Figure 6 One of the schematic diagrams of the end of the journey.

[0025] Figure 7(a) shows one of the schematic diagrams of the end of the stroke.

[0026] Figure 7(b) shows the second schematic diagram of the end of the stroke.

[0027] Figure 8(a) One of the schematic diagrams of an explosion at the end of the stroke.

[0028] Figure 8(b) Schematic diagram of the end of the stroke (Part 3).

[0029] Figure 9(a) Schematic diagram of the end of the stroke (Part 4).

[0030] Figure 9(b) Second schematic diagram of the explosion at the end of the stroke.

[0031] Figure 9(c) shows the fifth schematic diagram of the end of the stroke.

[0032] Figure 10(a) One of the schematic diagrams of the anesthetic guidance path.

[0033] Figure 10(b) Schematic diagram of the anesthetic guidance path (Part 2).

[0034] Figure 10(c) Schematic diagram of the anesthetic guidance path (Part 3).

[0035] Figure 10(d) Schematic diagram of the anesthetic guidance path (Part 4).

[0036] Figure 10(e) Schematic diagram of the anesthetic guidance path (Part 5).

[0037] Explanation of reference numerals in the attached drawings: Treatment execution device 1; Stroke termination end 11; Annular contact surface 101; Segmented annular contact surface 102; Contact surface gap 103; Flow channel 110; First surface of stroke termination end 111; Second surface of stroke termination end 112; Groove 113; Operation window 114; Fluid pipe 1141; First window 1143; Second window 1142; Connector 115; Opening end 116; First flow channel 117; Second flow channel 118; First through port 120; Second through port 1201; Stroke advancement end 12; First surface of stroke advancement end 121; Liner 13; Main unit 2; Eyeball 9. Detailed Implementation

[0038] The embodiments of the technical solution of the present invention will now be described in detail with reference to the accompanying drawings. These embodiments are merely illustrative of the technical solution of the present invention and are therefore intended to limit the scope of protection of the present invention.

[0039] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains; the terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the invention; the terms “comprising” and “having”, and any variations thereof, in the specification, claims, and foregoing description of the invention, are intended to cover non-exclusive inclusion.

[0040] In the description of the embodiments of this invention, technical terms such as "first" and "second" are used only to distinguish different objects and should not be construed as indicating or implying relative importance or implicitly specifying the number, specific order, or primary and secondary relationship of the indicated technical features. In the description of the embodiments of this invention, "multiple" means two or more, unless otherwise explicitly defined.

[0041] In the description of embodiments of the present invention, the term "multiple" refers to two or more (including two).

[0042] Massage therapy for dry eye As a vital sensory organ, the eyes require careful treatment to address not only the underlying condition but also to prevent further damage during treatment. Dry eye treatment often involves procedures on the ocular surface (such as meibomian gland massage, IPL-assisted eyelid margin cleaning, lacrimal duct plug implantation, and removal of foreign bodies) or addresses severe ocular surface damage (such as dry eye-related corneal epithelial defects). The key to treating dry eye syndrome lies in heating and massaging the eyelids. This heating and massage help to expel blockages from the meibomian glands, clearing blockages and relieving dry eye symptoms.

[0043] An ocular anesthetic is applied before or during eyelid heating and massage. Commonly used ocular anesthetics (such as promecaine, lidocaine, and oxybuprofen) are "local surface anesthetics." They diffuse to the ocular surface after being instilled into the conjunctival sac, which serves as the drug delivery channel. The anesthetic primarily acts on the cornea, with secondary effects on the conjunctiva. The conjunctival sac is a potential cavity between the eyelid and the eyeball (formed by conjunctival folds), a natural space for ocular medication. After the anesthetic is instilled into the conjunctival sac, it is evenly distributed across the corneal and conjunctival surfaces through blinking, and then takes effect through epithelial penetration. The conjunctival sac itself lacks sensory nerve endings and is not part of the anesthetic's "target area," serving only to "carry the medication and assist in diffusion." The cornea is the most sensitive tissue on the ocular surface, rich in sensory nerve endings of the ophthalmic branch of the trigeminal nerve (especially since any slight touch (such as cotton swabs, medication, or instruments affecting the corneal epithelium and subepithelial nerve plexus)) can trigger severe pain. In dry eye treatment, if corneal-related procedures are involved (such as corneal foreign body removal or corneal epithelial scraping), or if the patient has corneal epithelial defects (a common complication of severe dry eye), the anesthetic will preferentially act on the corneal epithelium, blocking the transmission of pain signals from nerve endings and quickly relieving the stinging sensation. Clinical observations show that after topical anesthetic instillation, corneal pain disappears the fastest (usually taking effect within 30 seconds to 1 minute), making it the primary target area for anesthesia. The conjunctiva (divided into palpebral conjunctiva, bulbar conjunctiva, and fornix conjunctiva) also contains sensory nerve endings. Although its sensitivity is lower than that of the cornea, contact with the conjunctiva during procedures (such as touching the facial conjunctiva during meibomian gland massage or touching the bulbar conjunctiva during eyelid cleaning before IPL treatment) may still cause a foreign body sensation or mild pain. After the anesthetic is instilled into the conjunctival sac, it will diffuse to the conjunctival surface with the medication, acting on the nerve endings in the conjunctival epithelium to reduce this type of irritation (such as the pressure pain on the facial conjunctiva during meibomian gland squeezing). The anesthetic effect of the conjunctiva is weaker than that of the cornea, and the duration is shorter (usually 10-15 minutes). The dosage of anesthetic will be adjusted according to the operation site (for example, an additional drop may be needed for conjunctival-related operations).

[0044] Treatment execution device like Figure 1 As shown, this is a treatment execution device 1 and a host computer 2 that controls the treatment execution device. The treatment execution device can be installed on the patient's eye, such as... Figure 2 As shown, after installation, the travel termination end 11 covers a portion of the eyeball 9. The eyelid (not shown in the figure) is located between the travel termination end and the travel advancement end 12. That is, the first surface 111 of the travel termination end partially contacts the eyeball, the second surface 112 of the travel termination end contacts the inner surface of the eyelid, and the first surface 121 of the travel advancement end contacts the outer surface of the eyelid. The inner surface of the eyelid refers to the surface that contacts the eyeball when the eyes are closed, and the outer surface of the eyelid refers to the surface exposed to the air when the eyes are closed. Figure 3 As shown, there are two different structures of treatment execution devices, in which... Figure 3 In (a), the first surface 111 at the end of the stroke is smooth. Figure 3 (b) A groove 113 is provided on the first surface 111 at the end of the stroke. For example Figure 4 As shown, after the treatment device is installed in the patient's eye, Figure 3 (a) The contact surface between the first surface at the end of the stroke and the eyeball 9 is as follows Figure 4 (a) shows the annular contact surface 101, forming a sealed air chamber between the eyeball and the end of the travel; Figure 3 (b) The contact surface between the first surface at the end of the stroke and the eyeball 9 is as follows Figure 4 (b) shows a segmented annular contact surface 102. The contact surface gap 103 on the segmented annular contact surface is formed due to the presence of the groove 113, forming an unsealed air chamber between the eyeball and the end of the stroke.

[0045] In some implementations, the treatment actuator can always maintain a state in which the end of the stroke and the advance of the stroke are fixedly connected together, such as... Figure 5 As shown in (b), the travel advance end is directly above the travel termination end, allowing the inner surface of the eyelid to contact the second surface 112 of the travel termination end, and the outer surface of the eyelid to contact the first surface of the travel advance end. In some embodiments, the treatment execution device includes two states. In the first state, the operator cannot control the travel advance end to produce a gradual travel towards the travel termination end, that is, the operator cannot control the travel advance end to produce a gradual travel relative to the patient's eyelid, such as... Figure 5 As shown in (a), the travel advance end is obliquely above the travel termination end, allowing the inner surface of the eyelid to contact the second surface 112 of the travel termination end, while the first surface of the travel advance end is far from the outer surface of the eyelid, resulting in a larger operable space around the travel termination end. In the second state, the operator can control the travel advance end to gradually travel towards the travel termination end, that is, the operator can control the travel advance end to gradually travel relative to the patient's eyelid, such as... Figure 5 As shown in (b), the travel advance end is directly above the travel termination end, allowing the inner surface of the eyelid to contact the second surface 112 of the travel termination end, and the outer surface of the eyelid to contact the first surface of the travel advance end.

[0046] End of journey like Figure 6 As shown, there are two structures for the stroke termination end 11, both of which are equipped with an operation window 114. Figure 6 (a) The first structure shown has a stroke termination end including a stroke termination end first surface 111, a stroke termination end second surface 112, an operation window 114 and a connector 115, wherein the operation window 114 is located near the connector and extends through the stroke termination end first surface and the stroke termination end second surface, and the stroke termination end first surface and the stroke termination end second surface intersect at an opening end 116. Figure 6 (b) The second structure shown includes a stroke termination end comprising a first stroke termination end surface 111, a second stroke termination end surface 112, an operation window 114, and a connector 115. The operation window 114 is located near the connector and includes a first window 1143 penetrating both the first and second stroke termination end surfaces, a fluid pipe 1141 extending towards the connector, and a second window 1142 on the fluid pipe. The first and second stroke termination end surfaces intersect at an open end 116. In actual production, the first and second stroke termination end surfaces may be integrally formed. The description of the first and second stroke termination end surfaces is to distinguish between the surface in contact with the eyeball and the surface in contact with the eyelid. When the device is used, after the first stroke termination end surface abuts against the eyeball, a non-sealed air chamber is formed between the eyeball and the first stroke termination end surface through the operation window, preventing damage to the eyeball from heat released from the eyecup.

[0047] Trip Progress End like Figure 2 , Figure 3 , Figure 5 As shown, the travel advance end 12 and the travel end 11 are fixedly or movably connected. The travel advance end is used to advance or retract the travel towards the travel end, that is, to shorten or widen the gap between the travel advance end and the travel end, thereby achieving cyclical massage of the eyelid. In some embodiments, the travel advance end advances the travel by expanding and retracts the travel by contracting; in some embodiments, the travel advance end advances the travel by moving towards the travel end and retracts the travel by moving away from the travel end.

[0048] flow channel Figures 7-9 show examples of different forms of flow channels at the end of the stroke.

[0049] As shown in Figure 7(a), the flow channel 110 is connected to the operation window 114. The flow channel extends from the operation window toward the opening end 116 and passes through the first and second surfaces of the stroke termination end. In the figure, the flow channel makes the opening end appear as a notch. Of course, the flow channel may not extend to the opening end, leaving the opening end in a closed state, as long as the endpoint of the flow channel extending from the operation window to the opening end corresponds to the eyelid. As shown in Figure 7(b), the flow channel 110 is connected to the operation window 114. The flow channel extends from the operation window toward the opening end 116 and is only located on the second surface 112 of the stroke termination end. In the figure, the endpoint of the flow channel extending from the operation window to the opening end does not reach the opening end. However, the endpoint of the flow channel extending from the operation window to the opening end can also be located on the opening end.

[0050] As shown in Figure 8(a), the first surface of the stroke termination end and the second surface of the stroke termination end are separated by the opening end. The figure only shows the reverse side of the first surface of the stroke termination end, the second surface of the stroke termination end, and the connector. It can be seen that the operation window 114 passes through the first surface of the stroke termination end and the second surface of the stroke termination end. The first flow channel 117 is connected to the operation window 114. The first flow channel extends from the operation window towards the opening end 116 and is only set on the second surface of the stroke termination end 112. The second flow channel 118 is only set on the reverse side of the first surface of the stroke termination end and extends in the opposite direction of the extension direction of the first flow channel. It passes through the second surface of the stroke termination end at the first through-hole 120 at the extension end but does not pass through the first surface of the stroke termination end. In this way, the end point of the first flow channel and the end point of the second flow channel correspond to the two eyelids of the eye, respectively. As shown in Figure 8(b), (I) and (II) are schematic diagrams of the second surface of the stroke termination end and the connector from two different perspectives after the first surface of the stroke termination end is completely deleted. It can be seen that the operation window 114 penetrates the first surface of the stroke termination end (not shown but also penetrates the second surface of the stroke termination end). The first flow channel 117 is connected to the operation window 114. The first flow channel extends from the operation window towards the opening end 116 and is only set on the second surface 112 of the stroke termination end. The second flow channel 118 is only set on the opposite side of the second surface of the stroke termination end and extends in the opposite direction of the extension direction of the first flow channel. It penetrates the second surface of the stroke termination end at the first through-hole 120 at the extension end but does not penetrate the first surface of the stroke termination end. In this way, the end point of the first flow channel and the end point of the second flow channel correspond to the two eyelids of the eye, respectively. Figures 8(a) and 8(b) illustrate the placement of the second flow channel when the first flow channel is only located on the second surface of the stroke termination end. Generally, the second flow channel is located between the first and second surfaces of the stroke termination end. In addition to the examples shown, a liner may also be included between the first and second surfaces of the stroke termination end, and the second flow channel is located on the liner. Furthermore, the first through-hole 120 can extend in the opposite direction to the first flow channel so that the extension endpoint is closer to the opening end, forming a third flow channel. The third flow channel communicates with the second flow channel through the first through-hole. The aforementioned opposite direction is not limited to a 180-degree rotation; it can also be any other rotation angle, as long as the first flow channel and the first through-hole correspond to the two eyelids of the eye, or the first flow channel and the third flow channel correspond to the two eyelids of one eye, respectively.

[0051] As shown in Figure 9(a), the first surface of the stroke termination end and the second surface of the stroke termination end are separated by the opening end. Figure 9(a)(Ⅰ) only shows the second surface of the stroke termination end and the connector. It can be seen that the operation window 114 penetrates the second surface of the stroke termination end (not shown but also penetrates the first surface of the stroke termination end). The operation window extends a fluid pipe 1141 in the direction of the connector 115. The first flow channel 117 is connected to the operation window 114. The first flow channel extends from the operation window in a direction away from the operation window and is only set on the opposite side of the second surface of the stroke termination end. It penetrates the second surface of the stroke termination end but does not penetrate the first surface of the stroke termination end at the first through-hole 120 at the end of the extension. In this way, the end point of the first flow channel can correspond to an eyelid. Figure 9(a) (II) only shows the reverse side of the first surface of the stroke termination end. It can be seen that the operation window 114 penetrates the first surface of the stroke termination end (not shown, but it also penetrates the second surface of the stroke termination end). The first flow channel 117 communicates with the operation window 114. The first flow channel extends from the operation window in a direction away from the operation window and is only set on the reverse side of the first surface of the stroke termination end. At the first through-hole 120 at the extension end, it penetrates the second surface of the stroke termination end (not shown) but does not penetrate the first surface of the stroke termination end. In this way, the end point of the first flow channel can correspond to an eyelid. As shown in Figure 9(b), the first and second surfaces of the stroke termination end are separated by the open end. Only the reverse side of the first surface of the stroke termination end, the second surface 112 of the stroke termination end, the connector 115, and the liner 13 are shown. It can be seen that the operating window 114 penetrates the first surface of the stroke termination end and the liner (not shown, but it also penetrates the second surface of the stroke termination end). The operating window extends a fluid tube 1141 in the direction of the connector 115. The fluid tube is provided with a sample inlet 1142. The first flow channel 117 is provided on the liner and communicates with the operating window 114. It extends from the operating window in a direction away from the operating window. At the first through-hole 120 at the end of the extension, it penetrates the second surface of the stroke termination end but does not penetrate the first surface of the stroke termination end. In this way, the end point of the first flow channel can correspond to an eyelid. As shown in Figure 9(c), the first surface and the second surface of the stroke termination end are separated by the opening end. Figure 9(c)(I) only shows the second surface of the stroke termination end and the connector. It can be seen that the operation window 114 penetrates the second surface of the stroke termination end (not shown but also penetrates the first surface of the stroke termination end). The first flow channel 117 and the second flow channel 118 are connected to the operation window 114. The first flow channel and the second flow channel extend from the operation window away from the operation window and are only set on the opposite side of the second surface of the stroke termination end. They penetrate the second surface of the stroke termination end at the first through-hole 120 and the second through-hole 1201 at the extension endpoints, respectively, but do not penetrate the first surface of the stroke termination end. In this way, the endpoints of the first flow channel and the second flow channel can correspond to the two eyelids of one eye, respectively.Figure 9(c) (II) only shows the reverse side of the first surface of the stroke termination end. It can be seen that the operating window 114 penetrates the first surface of the stroke termination end (not shown, but it also penetrates the second surface of the stroke termination end). The first flow channel 117 and the second flow channel 118 communicate with the operating window 114. The first and second flow channels extend from the operating window in a direction away from the operating window and are only located on the reverse side of the first surface of the stroke termination end. At the extension endpoints, the first through-hole 120 and the second through-hole 1201 penetrate the second surface of the stroke termination end (not shown) but not the first surface of the stroke termination end. Thus, the endpoints of the first and second flow channels can respectively correspond to the two eyelids of one eye. The above example illustrates the case where the first (and second) flow channels are located between the first and second surfaces of the stroke termination end. They can also be located only on the reverse side of the first surface of the stroke termination end, or only on the reverse side of the second surface of the stroke termination end, or on the liner between the first and second surfaces of the stroke termination end. Example 1

[0052] Combining such Figure 3 (a) and Figure 6 (a) The treatment actuator with the structure is installed in the patient's eye, such that the first surface of the end of the stroke is perpendicular to the eyeball. Figure 4 (a) shows the annular contact surface, where the second surface of the stroke termination end abuts against the inner surface of the eyelid. In other words, the eyelid wraps the eye cup, which is composed of the first surface of the stroke termination end and the second surface of the stroke termination end, in the gap between the eyeball and the eyelid. The first surface of the stroke termination end and the eyeball form a non-sealed air cavity due to the operation window. The operation window 114 communicates with the external environment, thereby avoiding pressure difference and damage to the eyeball. The stroke advancement end is maintained in a state of partially abutting against the outer surface of the eyelid or not abutting against the outer surface of the eyelid at all.

[0053] The treatment actuator is controlled by a main unit. The air pump in the main unit receives commands to draw in gas, continuously inflating the propulsion end. This causes the propulsion end to gradually advance relative to the patient's eyelid. During this process, the patient is reminded to pay attention to and report any pain caused by the pressure. When the patient reports that the pain has reached their tolerance limit, the air pump, receiving commands from the main unit, stops drawing in gas, thus ceasing inflation of the propulsion end. This stops the gradual advance of the propulsion end relative to the patient's eyelid, allowing the determination of the maximum usable treatment pressure. The range from the initial value to the maximum value represents the patient's treatment pressure range. Then, the air pump, receiving commands from the main unit, releases gas, deflating the propulsion end and causing it to gradually recede relative to the patient's eyelid. In other embodiments, the air pump, receiving commands from the main unit, stops drawing in gas and releases gas, thus ceasing inflation and deflating the propulsion end, causing it to gradually recede relative to the patient's eyelid.

[0054] The treatment device remains installed on the patient's eye, with the eyelid still positioned between the end of the travel and the advance end. Local anesthetic is applied to the patient's eye through the operating window on the end of the travel. The anesthetic enters the gap between the first surface of the end of the travel and the eyeball through the operating window. Since the first surface of the end of the travel and the eyeball form a ring-shaped contact surface, the anesthetic, after entering the aforementioned gap, infiltrates the area within the ring-shaped contact surface between the patient's eyeball and the first surface of the end of the travel. If an excessive amount of anesthetic is added, it will overflow from the operating window and be guided by the second surface of the end of the travel to the edge of the eyelid near the operating window, thus providing a certain anesthetic effect to the eyelid.

[0055] The treatment device is controlled by a main unit. The air pump in the main unit, upon receiving commands, draws in gas to continuously inflate the propulsion end, causing it to gradually advance relative to the patient's eyelid, applying pressure within the treatment pressure range. Then, when the treatment pressure applied through this gradual advance reaches the maximum value of the treatment pressure range (or before), the air pump in the main unit, upon receiving commands, releases gas to continuously deflate the propulsion end, causing it to gradually recede relative to the patient's eyelid. Then, when the treatment pressure applied through this receding stroke reaches the minimum value of the treatment pressure range (or before), or when the first surface of the propulsion end no longer contacts the outer surface of the eyelid, the air pump in the main unit, upon receiving commands, draws in gas to continuously inflate the propulsion end, causing it to gradually advance relative to the patient's eyelid, applying pressure within the treatment pressure range. This gradual advance and receding stroke occurs cyclically to create a massage and squeezing effect, facilitating the expulsion of lipids from the meibomian glands, until the treatment cycle has elapsed, ending the treatment. Example 2

[0056] Combining such Figure 3 The treatment actuators with the structures shown in (a) and 7(a) are installed on the patient's eye, such that the first surface of the end of the stroke is perpendicular to the eyeball. Figure 4 (a) shows the annular contact surface. Unlike Example 1, local anesthetic is applied to the patient's eye through the operation window 114 on the end of the stroke. The anesthetic enters the gap between the first surface of the end of the stroke and the eyeball through the operation window. Since the first surface of the end of the stroke and the eyeball form an annular contact surface, the anesthetic enters the aforementioned gap and infiltrates the area within the annular contact surface between the patient's eyeball and the first surface of the end of the stroke. When an excessive amount of anesthetic is added, the anesthetic will fill the aforementioned area and overflow towards the second surface of the end of the stroke through the flow channel and the operation window, thereby being guided to the eyelid corresponding to the flow channel and exerting a certain anesthetic effect. Example 3

[0057] Combining such Figure 3The treatment actuators with the structures shown in (a) and 7(b) are installed on the patient's eye such that the first surface of the end of the stroke is perpendicular to the eyeball. Figure 4 (a) shows the annular contact surface, where the second surface of the stroke termination end abuts against the inner surface of the eyelid. In other words, the eyelid wraps the eye cup, which is composed of the first surface of the stroke termination end and the second surface of the stroke termination end, in the gap between the eyeball and the eyelid. A non-sealed air cavity is formed between the first surface of the stroke termination end and the eyeball, while the stroke advancement end is maintained in a state of partially abutting against the outer surface of the eyelid or not abutting against the outer surface of the eyelid at all.

[0058] The host computer controls the treatment actuator. It commands the propulsion end to move towards the patient's eyelid to create a gradual movement. During this process, the patient is reminded to pay attention to and report any pain caused by the pressure. When the patient reports that the pain has reached their tolerance limit, the host computer commands the propulsion end to stop moving, ceasing the gradual movement. At this point, the maximum usable treatment pressure for the patient can be obtained. The range from the initial value to the maximum value represents the patient's treatment pressure range. The host computer then commands the propulsion end to move away from the patient's eyelid, creating a gradual retraction relative to the eyelid. In other embodiments, the host computer commands the propulsion end to stop moving towards the patient's eyelid and to move away from the patient's eyelid, creating a gradual retraction relative to the eyelid.

[0059] The treatment device is kept in place on the patient's eye. At this time, the eyelid is still located between the end of the stroke and the advance of the stroke. Local anesthetic is applied to the patient's eye through the operation window 114 on the end of the stroke. The anesthetic enters the gap between the first surface of the end of the stroke and the eyeball through the operation window. Since the first surface of the end of the stroke and the eyeball form an annular contact surface, the anesthetic enters the aforementioned gap and infiltrates the area within the annular contact surface between the patient's eyeball and the first surface of the end of the stroke. The anesthetic continues to rise along the inner wall of the operation window to the intersection of the operation window and the flow channel 110 set on the second surface of the end of the stroke and enters the flow channel. Since the inner side of the eyelid covers the flow channel 110, the flow channel guides the anesthetic to flow in the flow channel, thus anestheticizing the eyelid covered by the flow channel.

[0060] The host computer controls the treatment actuator. It commands the propulsion end to move towards the patient's eyelid to create a progressive stroke, applying pressure within the treatment pressure range. Then, when the applied treatment pressure reaches the maximum value of the treatment pressure range (or before), the host computer commands the propulsion end to move away from the patient's eyelid to create a receding stroke. Then, when the applied treatment pressure reaches the minimum value of the treatment pressure range (or before), or when the first surface of the propulsion end no longer contacts the outer surface of the eyelid, the host computer commands the propulsion end to move towards the patient's eyelid to create a progressive stroke, applying pressure within the treatment pressure range. The aforementioned progressive and receding strokes occur cyclically to create a massage and squeezing effect, facilitating the expulsion of lipids from the meibomian glands, until the treatment cycle has elapsed, ending the treatment. Example 4

[0061] Combining such Figure 3 (b) The treatment actuator with the structure of Figure 8(a) (or Figure 8(b)) is installed on the patient's eye such that the first surface of the end of the stroke is perpendicular to the eyeball. Figure 4 (b) shows a segmented annular contact surface. The second surface of the stroke termination end abuts against the inner surface of the eyelid. In other words, the eyelid wraps the eye cup, which is composed of the first surface of the stroke termination end and the second surface of the stroke termination end, in the gap between the eyeball and the eyelid. A non-sealed air cavity is formed between the first surface of the stroke termination end and the eyeball. It is connected to the external environment through the operation window 114 and the groove 113 to avoid pressure difference and damage to the eyeball. The stroke advancement end is maintained in a state of partially abutting against the outer surface of the eyelid or not abutting against the outer surface of the eyelid at all, but can gradually move towards the second surface of the stroke termination end.

[0062] The host controls the treatment actuator. The air pump in the host receives commands to draw in gas, continuously inflating the propulsion end. This causes the propulsion end to gradually advance relative to the patient's eyelid. During this process, the patient is reminded to pay attention to the pain caused by the pressure and provide feedback. When the patient reports that the pain has reached the tolerance limit, the air pump receives commands from the host to stop drawing in gas and expel gas, thus stopping the inflation and deflation of the propulsion end. This causes the propulsion end to gradually recede relative to the patient's eyelid. At this point, the maximum treatment pressure that the patient can use can be obtained. The range from the initial value to the maximum value is the patient's treatment pressure range.

[0063] The treatment device remains installed in the patient's eye, with the eyelid still positioned between the end of the travel and the advance of the travel. Local anesthetic is applied to the patient's eye through the operation window 114 on the end of the travel. The anesthetic enters the gap between the first surface of the end of the travel and the eyeball through the operation window. Because the first surface of the end of the travel and the eyeball form a segmented annular contact surface, the anesthetic, upon entering the aforementioned gap, permeates the area within the annular contact surface between the patient's eyeball and the first surface of the end of the travel, while simultaneously permeating the area of ​​the eyeball outside the aforementioned area through the groove. Furthermore, the anesthetic rises along the inner wall of the operation window to the area between the operation window and the eyeball. The anesthetic agent is placed at the intersection of the second flow channel 118 on the opposite side of the first surface at the end of the stroke and enters the second flow channel. It passes through the end point of the second flow channel, namely the first through-hole 120, and the overflowing anesthetic agent has an anesthetic effect on the corresponding eyelid (upper eyelid or lower eyelid). The anesthetic agent continues to rise along the inner wall of the operating window to the intersection of the operating window and the first flow channel 117 placed on the second surface at the end of the stroke and enters the first flow channel. Since the inner side of the eyelid covers the first flow channel 117, the first flow channel guides the anesthetic agent to flow in the first flow channel and has an anesthetic effect on the eyelid (lower eyelid or upper eyelid) covering the first flow channel.

[0064] The treatment device is controlled by a main unit. The air pump in the main unit, upon receiving commands, draws in gas to continuously inflate the propulsion end, causing it to gradually advance relative to the patient's eyelid, applying pressure within the treatment pressure range. Then, when the treatment pressure applied through this gradual advance reaches the maximum value of the treatment pressure range (or before), the air pump in the main unit, upon receiving commands, releases gas to continuously deflate the propulsion end, causing it to gradually recede relative to the patient's eyelid. Then, when the treatment pressure applied through this receding stroke reaches the minimum value of the treatment pressure range (or before), or when the first surface of the propulsion end no longer contacts the outer surface of the eyelid, the air pump in the main unit, upon receiving commands, draws in gas to continuously inflate the propulsion end, causing it to gradually advance relative to the patient's eyelid, applying pressure within the treatment pressure range. This gradual advance and receding stroke occurs cyclically to create a massage and squeezing effect, facilitating the expulsion of lipids from the meibomian glands, until the treatment cycle has elapsed, ending the treatment. If anesthesia fails during the entire treatment, the cycle of progressive and regressive procedures can be paused, and local anesthetic can be administered again through the operating window before resuming the cycle of progressive and regressive procedures.

[0065] In another embodiment, when the local anesthetic is applied, the anesthetic enters the third channel after reaching the first incision. Since the inner side of the eyelid covers the third channel, the third channel guides the anesthetic to flow within it, thus anestheticizing the eyelid (upper or lower eyelid) covered by the third channel. Example 5

[0066] Combining such Figure 3 (b) The treatment actuator with the structure of Figure 9(a) (or Figure 9(b)) is installed on the patient's eye. When installation is not complete, the travel advance end is in the position as shown in Figure 9(a). Figure 5 (a) shows a state where the movement is away from the outer surface of the eyelid and cannot proceed towards the second surface of the stroke termination end. During installation, the first surface of the stroke termination end should be positioned such that it is perpendicular to the eyeball. Figure 4 (b) shows a segmented annular contact surface, with the second surface of the stroke termination end abutting against the inner surface of the eyelid, forming a non-sealed cavity between the eyeball and the stroke termination end. Subsequently, the state of the stroke advancement end is changed, causing the stroke advancement end to rotate around its connection point with connector 115 until... Figure 5 (b) shows a state where the travel advance end is close to the outer side of the eyelid and can gradually move towards the second side of the travel end (in this state, the travel advance end part is in contact with the outer side of the eyelid or not in contact with the outer side of the eyelid at all).

[0067] The host controls the treatment actuator. The host commands the travel advance end to move towards the patient's eyelid to generate a gradual travel. During this process, the patient is reminded to pay attention to the pain caused by the pressure and provide feedback. When the patient reports that the pain has reached the tolerance limit, the host commands the travel advance end to stop moving so that no more gradual travel is generated. At this point, the maximum treatment pressure that the patient can use can be obtained. The range from the initial value to the maximum value is the patient's treatment pressure range. Then, the host commands the travel advance end to stop moving towards the patient's eyelid and to move away from the patient's eyelid, so that the travel advance end generates a gradual retraction relative to the patient's eyelid.

[0068] With the treatment actuator still mounted on the patient's eye, the state of the travel advance end is changed so that it rotates around its connection point with connector 115 until... Figure 5 As shown in (a), in a state where the process is far from the outer surface of the eyelid and cannot proceed towards the second surface of the end of the flow, a local anesthetic is applied to the patient's eye through the operating window on the end of the flow. The anesthetic enters from the second window 1142 and flows along the inner wall 1141 of the fluid tube to the first window, then enters the gap between the first surface of the end of the flow and the eyeball. Since the first surface of the end of the flow and the eyeball form a segmented annular contact surface, the anesthetic, on the one hand, enters the aforementioned gap and infiltrates the area within the annular contact surface between the patient's eyeball and the first surface of the end of the flow, and on the other hand, infiltrates the area of ​​the eyeball outside the aforementioned area through the groove. The anesthetic, on the other hand, rises along the inner wall of the operating window to the intersection of the first window and the first flow channel 117, and then flows in the first flow channel to the first through-hole 120, and is guided along the first through-hole to cover the upper eyelid, thereby numbing the eyelid.

[0069] Change the state of the travel advance end so that it rotates around its connection point with the connector 115 until... Figure 5 (b) shows the state where the device is close to the outer surface of the eyelid and can gradually advance towards the second surface of the end of the stroke. The host controls the treatment actuator, commanding the stroke advance end to move towards the patient's eyelid to generate a gradual stroke and apply pressure within the treatment pressure range. Then, when the treatment pressure applied through the gradual stroke reaches the maximum value of the treatment pressure range (or before), the host commands the stroke advance end to move away from the patient's eyelid to generate a gradual retreat stroke. Then, when the treatment pressure applied through the gradual retreat stroke reaches the minimum value of the treatment pressure range (or before), or when the first surface of the stroke advance end no longer contacts the outer surface of the eyelid, the host commands the stroke advance end to move towards the patient's eyelid to generate a gradual stroke and apply pressure within the treatment pressure range. The aforementioned gradual and retreat strokes occur cyclically to produce a massage and squeezing effect, facilitating the expulsion of lipids from the meibomian glands, until the treatment cycle has elapsed and the treatment ends. During the entire treatment process, if anesthesia fails, the cycle of gradual and retreat strokes can be paused, and the stroke advance end can be changed to... Figure 5 (a) shows the state, and after supplementing the local anesthetic through the operation window, the travel advancement end is then changed to the position shown in (a). Figure 5 (b) shows the state, followed by a cycle of gradual progress and gradual regression.

[0070] In another embodiment, it incorporates, such as Figure 3 The treatment device with the structures shown in (b) and 9(c) is installed on the patient's eye. When a local anesthetic is applied, the anesthetic rises along the inner wall of the operating window to the intersection of the first window, the first flow channel 117, and the second flow channel 118. Then, it flows in the first flow channel to the first through-hole 120 and is guided along the first through-hole to cover the upper eyelid. In the second flow channel, it flows to the second through-hole 1201 and is guided along the second through-hole to cover the upper eyelid, thus numbing both eyelids.

[0071] In another implementation, the state of the travel propulsion end is not changed before or after the application of local anesthetic. That is, after the treatment device is installed in the patient's eye, the first change in the state of the travel propulsion end is the last change. Example 6

[0072] Local anesthetics are administered to the patient's eyes through the operating window at the end of the procedure. There are various methods for anesthetizing both the eyeball and the eyelid. Taking a single eyelid as an example, the following explanation is provided.

[0073] As shown in Figure 10(a), the operating window 114 extends through the first end face 111 and the second end face 112 of the stroke termination point. The flow channel 110 intersects the operating window 114 at the middle of the operating window and is located between the first end face and the second end face of the stroke termination point. The first through-hole 120 extends from the end point of the flow channel to the second end face of the stroke termination point. The anesthetic enters through the operating window and is guided to the surface of the eyeball, passing through the intersection of the operating window and the flow channel. It then rises along the inner wall of the operating window to the intersection of the operating window and the flow channel and enters the flow channel. Guided by the flow channel, it is guided to the eyelid through the first through-hole.

[0074] As shown in Figure 10(b), the operating window 114 penetrates the second surface 112 at the end of the flow path. The flow channel 110 intersects the operating window 114 at the bottom of the operating window and is located between the first surface and the second surface at the end of the flow path. The first through-hole 120 penetrates from the middle of the flow channel to the second surface at the end of the flow path, and the second through-hole 1201 penetrates from the end of the flow channel to the first surface at the end of the flow path. The anesthetic enters through the operating window and enters the flow channel through the intersection of the operating window and the flow channel. When it passes through the first through-hole, it splits, continuing to flow forward in the flow channel on one hand, and being guided to the eyelid through the first through-hole on the other. The anesthetic that continues to flow forward is guided to the surface of the eyeball through the second through-hole at the end of the flow path.

[0075] As shown in Figure 10(c), the operating window 114 penetrates the second surface 112 at the end of the stroke. The flow channel 110 intersects the operating window 114 at the bottom of the operating window and is located between the first surface and the second surface at the end of the stroke. The first through-hole 120 penetrates from the end of the flow channel to the first surface at the end of the stroke and simultaneously to the second surface at the end of the stroke. The anesthetic enters through the operating window and passes through the intersection of the operating window and the flow channel. When the anesthetic flows along the flow channel and is guided to the end of the flow channel, it is guided to the surface of the eyeball through the first through-hole, and then rises along the inner wall of the first through-hole and is guided to the eyelid.

[0076] As shown in Figure 10(d), the operating window 114 penetrates the second surface 112 at the end of the flow path. The flow channel 110 intersects the operating window 114 at the bottom of the operating window and is located on the second surface at the end of the flow path. The first through-hole 120 extends from the end of the flow channel through both the first surface and the second surface at the end of the flow path. The anesthetic enters through the operating window and passes through the intersection of the operating window and the flow channel. As the anesthetic flows along the flow channel and is guided to the end of the flow channel, the eyelid comes into contact with the anesthetic. Then, the anesthetic is guided to the surface of the eyeball through the first through-hole at the end of the flow channel.

[0077] As shown in Figure 10(e), the operating window 114 extends through the first surface 111 and the second surface 112 of the end of the stroke. The flow channel 110 is integrated with the operating window 114, meaning the flow channel also extends through the first and second surfaces of the end of the stroke. The anesthetic enters through the operating window and is guided to the surface of the eyeball. Then, the anesthetic rises along the inner wall of the flow channel and is guided to the eyelid. This results in a large area of ​​contact between the eyelid and the anesthetic, and a relatively large amount of anesthetic needs to be added.

[0078] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features, or the technical solutions in the embodiments can be split and reorganized. These modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention, and they should all be covered within the scope of the claims and specification of the present invention. In particular, as long as there is no structural conflict, the various technical features mentioned in the various embodiments can be combined in any way. The present invention is not limited to the specific embodiments disclosed herein, but includes all technical solutions falling within the scope of the claims.

Claims

1. A dry eye massaging treatment method, characterized by, The method comprises the following steps: In the first step, the treatment execution device is installed on the patient's eye, so that the first surface of the travel termination end is in annular contact with the eyeball, and the second surface of the travel termination end is in abutment with the inner side of the eyelid, forming a non-hermetic cavity between the eyeball and the travel termination end; In the second step, the travel advancement end is controlled to generate a gradual travel relative to the patient's eyelid, and the generation of the gradual travel is stopped in response to the patient's pain feedback, and the treatment pressure range of the patient is obtained; In the third step, the treatment execution device is kept installed on the patient's eye, and a local anesthetic is applied to the patient's eye through the operation window on the travel termination end, and the anesthetic infiltrates the patient's eyeball through the operation window; In the fourth step, the travel advancement end is controlled to cyclically generate a gradual travel and a gradual retreat relative to the patient's eyelid to apply a pressure within the treatment pressure range.

2. The dry eye massagetherapy method according to claim 1, characterized by, In the third step, the anesthetic is also guided to the eyelid through the flow channel provided in the travel termination end.

3. The dry eye massagetherapy method according to claim 2, characterized by, The anesthetic first reaches the surface of the eyeball through the operation window, then rises along the inner wall of the operation window to the intersection of the operation window and the flow channel, and finally is guided to the eyelid through the flow channel.

4. The dry eye massagetherapy method according to claim 3, wherein The anesthetic is guided to one of the eyelids through a first flow channel provided in the travel termination end, and to the other eyelid through a second flow channel provided in the travel termination end.

5. The dry eye massagetherapy method according to claim 4, wherein The anesthetic rises along the inner wall of the operation window to the intersection of the operation window and the second flow channel, and then to the intersection of the operation window and the first flow channel, and is guided to one of the eyelids through the first flow channel and to the other eyelid through the second flow channel.

6. The dry eye massagetherapy method according to claim 5, wherein The anesthetic is guided to one of the eyelids through the first flow channel, and to the other eyelid through a third flow channel that communicates with the second flow channel.

7. The dry eye massagetherapy method according to claim 4, wherein The anesthetic rises along the inner wall of the operation window to the intersection of the operation window and the first flow channel and the second flow channel, and is guided to one of the eyelids through the first flow channel and to the other eyelid through the second flow channel.

8. The dry eye massagetherapy method according to claim 2, wherein The anesthetic first reaches the intersection of the operation window and the flow channel through the operation window, then is guided to the eyelid through the flow channel, and finally is guided to the surface of the eyeball through the through hole below the eyelid.

9. The dry eye massagetherapy method according to claim 8, wherein The anesthetic is guided to one of the eyelids through the first flow channel, and to the other eyelid through the second flow channel.

10. The dry eye massaging treatment method according to any one of claims 1 to 9, wherein The flow channel is provided on the second surface of the travel termination end.

11. The dry eye massaging treatment method according to any one of claims 1 to 9, wherein The flow channel is provided between the first surface of the travel termination end and the second surface of the travel termination end.

12. The dry eye massaging treatment method according to any one of claims 1 to 9, wherein In the first step, the first surface of the travel advancement end is in abutment with the outer side of the eyelid.

13. The dry eye massaging treatment method according to any one of claims 1 to 9, wherein In the first step, the first surface of the travel termination end is in segmented annular contact with the eyeball.

14. The dry eye massagetherapy method according to claim 10, wherein In the first step, the first surface of the travel termination end is in segmented annular contact with the eyeball.

15. The dry eye massagetherapy method according to claim 11, wherein In the first step, the first surface of the travel termination end is in segmented annular contact with the eyeball.

16. The dry eye massaging treatment method according to any one of claims 1-9, wherein, In the first step, the treatment execution device in the first state is installed on the patient's eye, and in the second step, the treatment execution device is first changed to the second state before being controlled.

17. The dry eye massagetherapy method according to claim 16, wherein In the third step, the first state of the treatment execution device is restored, and a local anesthetic is applied to the patient's eye through the operation window on the travel termination end; in the fourth step, the treatment execution device is restored to the second state, and the travel advancement end is controlled to generate a gradual travel and a gradual retreat relative to the patient's eyelid to apply a pressure within the treatment pressure range.

18. The dry eye massaging treatment method according to claim 14 or 15, wherein, In a first step, the treatment execution device in the first state is mounted to the patient's eye, in a second step the treatment execution device is first brought into the second state and then controlled.

19. The dry eye massagetherapy method according to claim 18, wherein, In a third step, the first state of the treatment execution device is restored and a local anesthetic is applied to the patient's eye through the operating window on the run-out end, in a fourth step the treatment execution device is brought back into the second state and the run-in and run-out strokes of the run-in end relative to the patient's eyelid are controlled to exert a pressure in the range of the treatment pressure.

Images